Investigación / Grupos de investigación

Grupo  301

Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Publicaciones (899)

  • Garcia-Portilla, MP; Gomar, J; Bobes-Bascaran, MT; Menendez-Miranda, I; Saiz, PA; Muniz, J; Arango, C; Patterson, T; Harvey, P; Bobes, J; Goldberg, T.

    Development of the Spanish Brief-version of the University of California Performance Skills Assessment (Sp-UPSA-Brief) in patients with schizophrenia and bipolar disorder

    Spanish Journal of Psychiatry and Mental Health. 2014; 7(3): 113-120 Nº de citas: 7 [doi:10.1016/j.rpsm.2014.02.003]

  • Diaz-Caneja, CM; Espliego, A; Parellada, M; Arango, C; Moreno, C.

    Polypharmacy with antidepressants in children and adolescents

    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2014; 17(7): 1063-1082 Nº de citas: 23 [doi:10.1017/S1461145712001265]

  • Calvo, A; Moreno, M; Ruiz-Sancho, A; Rapado-Castro, M; Moreno, C; Sanchez-Gutierrez, T; Arango, C; Mayoral, M.

    Intervention for Adolescents With Early-Onset Psychosis and Their Families: A Randomized Controlled Trial

    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2014; 53(6): 688-696 Nº de citas: 36 [doi:10.1016/j.jaac.2014.04.004]

  • Usall, J; Lopez-Carrilero, R; Iniesta, R; Roca, M; Caballero, M; Rodriguez-Jimenez, R; Oliveira, C; Bernardo, M; Corripio, I; Sindreu, SD; Piqueras, JCG; Felipe, AE; de Corres, BF; Ibanez, A; Huerta, R.

    Double-Blind, Placebo-Controlled Study of the Efficacy of Reboxetine and Citalopram as Adjuncts to Atypical Antipsychotics for Negative Symptoms of Schizophrenia

    JOURNAL OF CLINICAL PSYCHIATRY. 2014; 75(6): 608-615 Nº de citas: 18 [doi:10.4088/JCP.13m08551]

  • Navas-Sanchez, FJ; Aleman-Gomez, Y; Sanchez-Gonzalez, J; Guzman-De-Villoria, JA; Franco, C; Robles, O; Arango, C; Desco, M.

    White Matter Microstructure Correlates of Mathematical Giftedness and Intelligence Quotient

    HUMAN BRAIN MAPPING. 2014; 35(6): 2619-2631 Nº de citas: 106 [doi:10.1002/hbm.22355]

  • Martinez-Cengotitabengoa, M; Mico, JA; Arango, C; Castro-Fornieles, J; Graell, M; Paya, B; Leza, JC; Zorrilla, I; Parellada, M; Lopez, MP; Baeza, I; Moreno, C; Rapado-Castro, M; Gonzalez-Pinto, A.

    Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study

    Schizophrenia Research. 2014; 156(1): 23-29 Nº de citas: 44 [doi:10.1016/j.schres.2014.03.025]

  • Fleischhacker, WW; Arango, C; Arteel, P; Barnes, TRE; Carpenter, W; Duckworth, K; Galderisi, S; Halpern, L; Knapp, M; Marder, SR; Moller, M; Sartorius, N; Woodruff, P.

    Schizophrenia-Time to Commit to Policy Change

    SCHIZOPHRENIA BULLETIN. 2014; 40: 165-194 Nº de citas: 190 [doi:10.1093/schbul/sbu006]

  • Garcia-Bueno, B; Bioque, M; Mac-Dowell, KS; Barcones, MF; Martinez-Cengotitabengoa, M; Pina-Camacho, L; Rodriguez-Jimenez, R; Saiz, PA; Castro, C; Lafuente, A; Santabarbara, J; Gonzalez-Pinto, A; Parellada, M; Rubio, G; Garcia-Portilla, MP; Mico, JA; Bernardo, M; Leza, JC.

    Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia

    SCHIZOPHRENIA BULLETIN. 2014; 40(2): 376-387 Nº de citas: 138 [doi:10.1093/schbul/sbt001]

  • Arango, C; Fraguas, D; Parellada, M.

    Differential Neurodevelopmental Trajectories in Patients With Early-Onset Bipolar and Schizophrenia Disorders

    SCHIZOPHRENIA BULLETIN. 2014; 40: 138-146 Nº de citas: 103 [doi:10.1093/schbul/sbt198]

  • Cuerda, C; Velasco, C; Merchan-Naranjo, J; Garcia-Peris, P; Arango, C.

    The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity

    EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2014; 68(2): 146-152 Nº de citas: 52 [doi:10.1038/ejcn.2013.253]

  • Haro, JM; Ayuso-Mateos, JL; Bitter, I; Demotes-Mainard, J; Leboyer, M; Lewis, SW; Linszen, D; Maj, M; Mcdaid, D; Meyer-Lindenberg, A; Robbins, TW; Schumann, G; Thornicroft, G; Van der Feltz-Cornelis, C; Van Os, J; Wahlbeck, K; Wittchen, HU; Wykes, T; Arango, C; Bickenbach, J; Brunn, M; Cammarata, P; Chevreul, K; Evans-Lacko, S; Finocchiaro, C; Fiorillo, A; Forsman, AK; Hazo, JB; Knappe, S; Kuepper, R; Luciano, M; Miret, M; Obradors-Tarrago, C; Pagano, G; Papp, S; Walker-Tilley, T.

    ROAMER: roadmap for mental health research in Europe

    INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH. 2014; 23: 1-14 Nº de citas: 84 [doi:10.1002/mpr.1406]

  • Steinberg, S; de Jong, S; Mattheisen, M; Costas, J; Demontis, D; Jamain, S; Pietilainen, OPH; Lin, K; Papiol, S; Huttenlocher, J; Sigurdsson, E; Vassos, E; Giegling, I; Breuer, R; Fraser, G; Walker, N; Melle, I; Djurovic, S; Agartz, I; Tuulio-Henriksson, A; Suvisaari, J; Lonnqvist, J; Paunio, T; Olsen, L; Hansen, T; Ingason, A; Pirinen, M; Strengman, E; Hougaard, DM; Orntoft, T; Didriksen, M; Hollegaard, MV; Nordentoft, M; Abramova, L; Kaleda, V; Arrojo, M; Sanjuan, J; Arango, C; Etain, B; Bellivier, F; Meary, A; Schurhoff, F; Szoke, A; Ribolsi, M; Magni, V; Siracusano, A; Sperling, S; Rossner, M; Christiansen, C; Kiemeney, LA; Franke, B; van den Berg, LH; Veldink, J; Curran, S; Bolton, P; Poot, M; Staal, W; Rehnstrom, K; Kilpinen, H; Freitag, CM; Meyer, J; Magnusson, P; Saemundsen, E; Martsenkovsky, I; Bikshaieva, I; Martsenkovska, I; Vashchenko, O; Raleva, M; Paketchieva, K; Stefanovski, B; Durmishi, N; Milovancevic, MP; Tosevski, DL; Silagadze, T; Naneishvili, N; Mikeladze, N; Surguladze, S; Vincent, JB; Farmer, A; Mitchell, PB; Wright, A; Schofield, PR; Fullerton, JM; Montgomery, GW; Martin, NG; Rubino, IA; van Winkel, R; Kenis, G; De Hert, M; Rethelyi, JM; Bitter, I; Terenius, L; Jonsson, EG; Bakker, S; van Os, J; Jablensky, A; Leboyer, M; Bramon, E; Powell, J; Murray, R; Corvin, A; Gill, M; Morris, D; O'Neill, FA; Kendler, K; Riley, B; Craddock, N; Owen, MJ; O'Donovan, MC; Thorsteinsdottir, U; Kong, A; Ehrenreich, H; Carracedo, A; Golimbet, V; Andreassen, OA; Borglum, AD; Mors, O; Mortensen, PB; Werge, T; Ophoff, RA; Nothen, MM; Rietschel, M; Cichon, S; Ruggeri, M; Tosato, S; Palotie, A; St Clair, D; Rujescu, D; Collier, DA; Stefansson, H; Stefansson, K.

    Common variant at 16p11.2 conferring risk of psychosis

    MOLECULAR PSYCHIATRY. 2014; 19(1): 108-114 Nº de citas: 85 [doi:10.1038/mp.2012.157]

  • Parellada, M; Penzol, MJ; Pina, L; Moreno, C; Gonzalez-Vioque, E; Zalsman, G; Arango, C.

    The neurobiology of autism spectrum disorders

    EUROPEAN PSYCHIATRY. 2014; 29(1): 11-19 Nº de citas: 84 [doi:10.1016/j.eurpsy.2013.02.005]

  • Fraguas, D; del Rey-Mejias, A; Moreno, C; Castro-Fornieles, J; Graell, M; Otero, S; Gonzalez-Pinto, A; Moreno, D; Baeza, I; Martinez-Cengotitabengoa, M; Arango, C; Parellada, M.

    Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study

    Schizophrenia Research. 2014; 152(1): 130-138 Nº de citas: 54 [doi:10.1016/j.schres.2013.11.018]

  • de Portugal, E; Diaz-Caneja, CM; Gonzalez-Molinier, M; de Castro, MJ; del Amo, V; Arango, C; Cervilla, JA.

    Prevalence of premorbid personality disorder and its clinical correlates in patients with delusional disorder

    PSYCHIATRY RESEARCH. 2013; 210(3): 986-993 Nº de citas: 5 [doi:10.1016/j.psychres.2013.07.028]

  • Ramos, M; Boada, L; Moreno, C; Llorente, C; Romo, J; Parellada, M.

    Attitude and risk of substance use in adolescents diagnosed with Asperger syndrome

    DRUG AND ALCOHOL DEPENDENCE. 2013; 133(2): 535-540 Nº de citas: 34 [doi:10.1016/j.drugalcdep.2013.07.022]

  • Bioque, M; Garcia-Bueno, B; MacDowell, KS; Meseguer, A; Saiz, PA; Parellada, M; Gonzalez-Pinto, A; Rodriguez-Jimenez, R; Lobo, A; Leza, JC; Bernardo, M.

    Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis

    NEUROPSYCHOPHARMACOLOGY. 2013; 38(13): 2568-2577 Nº de citas: 71 [doi:10.1038/npp.2013.165]

  • Marder, SR; Alphs, L; Anghelescu, IG; Arango, C; Barnes, TRE; Caers, I; Daniel, DG; Dunayevich, E; Fleischhacker, WW; Garibaldi, G; Green, MF; Harvey, PD; Kahn, RS; Kane, JM; Keefe, RSE; Kinon, B; Leucht, S; Lindenmayer, JP; Malhotra, AK; Stauffer, V; Umbricht, D; Wesnes, K; Kapur, S; Rabinowitz, J.

    Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

    Schizophrenia Research. 2013; 150(2-3): 328-333 Nº de citas: 47 [doi:10.1016/j.schres.2013.07.058]